CreditReports.dk
HomeScreen companies

FERTIN PHARMA A/S Financials, key figures and credit report

CVR number: 25834844 Established 2001 Industry: 10 Manufacture of food products
Company contact details
Dandyvej 19, 7100 Vejle
Net sales 1 344.4 mDKK FY 2025 +6.4% vs 2024
EBIT margin -17.6 % FY 2025 +1.7 pp vs 2024
Net debt 1 647.0 mDKK FY 2025 +24.6% vs 2024
Quick ratio 1.6 FY 2025 +0.4 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales932.54892.581 012.571 263.841 344.39
Manufacturing for enterprise's own use73.2750.50
Other operating income1.752.10
Costs of manufacturing- 771.16- 867.42- 883.36- 361.11- 400.24
External services- 274.19- 280.10
Gross profit161.3825.16129.20703.56716.66
Costs of management-45.18-60.46-61.60
Costs of distribution-19.85-39.52-39.22
Employee benefit expenses- 650.67- 639.15
Other operating expenses-99.91-0.04-6.72
Total depreciation- 144.35- 129.01- 136.12- 297.31- 307.81
EBIT96.35-74.81-71.53- 244.47- 237.03
Other financial income1.140.134.0012.917.10
Other financial expenses-29.51-14.08-54.00- 126.33-88.28
Net income from associates (fin.)-13.07-24.83-41.45-84.02-25.94
Pre-tax profit54.91- 113.59- 162.97- 441.90- 344.15
Income taxes-17.2722.2126.2771.4363.30
Net earnings37.64-91.38- 136.70- 370.47- 280.84

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure289.37343.00407.36723.40616.57
Intangible rights83.17
Goodwill78.8273.89422.96387.83
Intangible assets total372.54421.82481.251 146.351 004.40
Land and waters496.38486.19456.63511.35493.99
Buildings485.34445.33418.68566.40564.22
Machinery and equipment6.714.684.447.874.98
Advance payments and construction in progress136.16240.27313.50183.70183.39
Tangible assets total1 124.591 176.471 193.251 269.331 246.58
Holdings in group member companies79.7165.7567.66119.4663.96
Other non-current investments155.36178.24
Investments total79.7165.7567.66274.81242.20
Long term receivables total
Semifinished products13.3930.0031.3628.8236.80
Raw materials and consumables124.06144.68145.58135.59148.51
Finished products/goods61.2943.9296.31108.47103.21
Inventories total198.75218.60273.25272.87288.52
Current trade debtors146.07156.79149.43180.46187.38
Current amounts owed by group member comp.55.83177.22315.00253.00359.29
Prepayments and accrued income3.296.0710.209.7212.19
Current other receivables4.280.352.3511.5915.35
Short term receivables total209.47340.44476.97454.77574.22
Cash and bank deposits36.4326.405.8215.6677.40
Cash and cash equivalents36.4326.405.8215.6677.40
Balance sheet total (assets)2 021.492 249.472 498.203 433.803 433.31

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital70.5170.5170.511 370.511 370.51
Other reserves238.19277.45318.20549.16462.87
Retained earnings335.06339.76206.4016.18- 282.64
Profit of the financial year37.64-91.38- 136.70- 370.47- 280.84
Shareholders equity total681.40596.35458.411 565.391 269.90
Provisions160.73139.98125.78153.33107.90
Non-current owed to group member1 564.541 272.421 600.00
Non-current other liabilities37.20
Non-current deferred tax liabilities36.9037.6956.1654.37
Non-current liabilities total37.2036.901 602.231 328.581 654.37
Current loans from credit institutions0.440.700.5623.10
Current trade creditors97.0484.88101.69113.66141.88
Current owed to group member950.661 237.2336.2564.41101.31
Short-term deferred tax liabilities7.016.47
Other non-interest bearing current liabilities87.45153.69173.15182.06111.71
Accruals and deferred income19.3423.14
Current liabilities total1 142.161 476.25311.79386.50401.14
Balance sheet total (liabilities)2 021.492 249.472 498.203 433.803 433.31
Page generated